Welcome!

News Feed Item

Boston Children's Hospital announces international genomics competition winner

Results will inform "best practices" for field where standards are lacking

SAN FRANCISCO, Nov. 7, 2012 /PRNewswire-USNewswire/ -- A first-of-its-kind international contest organized by Boston Children's Hospital, known as CLARITY, solves at least one family's genetic mystery while taking the first steps toward establishing "best practices" for using genomic sequencing in patient care safely, responsibly and in a meaningful way.

The contest winner, the Division of Clinical Genetics at Brigham and Women's Hospital, Boston, was one of 23 research groups competing to provide the best interpretation and communication of DNA sequencing results. Results were announced today at the American Society of Human Genetics (ASHG) annual meeting (Moscone Convention Center, hashtag #CLARITYDNA) and will be detailed in a forthcoming paper.

As testing costs go down, genomic sequencing is increasingly offered to patients, sometimes direct to consumer. Yet there haven't been standards for interpreting the voluminous DNA data, identifying actionable findings, communicating them to doctors and patients and dealing with unexpected, incidental findings.

"The community took this challenge very seriously, and we had tremendous participation," says CLARITY co-organizer David Margulies, MD, executive director of the Gene Partnership at Boston Children's Hospital. "We got the best thinking from around the world, and it has moved us toward a consensus on how to report sequencing data for use in the clinic."

The winning team was awarded $15,000. Two finalist teams were awarded $5,000 each: the University of Iowa and a German team comprised of Genomatix (Munich), CeGaT (Tubingen) and the Institute of Pathology at University Hospital of Bonn (Bonn).

Five additional teams received Special Mention for their contributions: the Clinical Institute of Medical Genetics (Ljubljana, Slovenia); The Research Institute at Nationwide Children's Hospital (Columbus, Ohio); Science for Life Laboratory (SciLifeLab) of the Karolinska Institute (Solna, Sweden); Scripps Genomic Medicine, Scripps Translational Science Institute (San Diego, Calif.); and a team comprised of SimulConsult (Chestnut Hill, Mass.) and Geisinger Health System (Danville, Pa.).

CLARITY's design

CLARITY (Children's Leadership Award for the Reliable Interpretation and appropriate Transmission of Your genomic information) was launched in January 2012. It challenged contestants to interpret DNA sequences from three children with rare conditions for which no genetic cause had been identified, selected by the Manton Center for Orphan Disease Research at Boston Children's Hospital. The children's identities were kept anonymous.

Of 40 research groups that submitted applications, 30 were selected to compete. Each received medical data for the three children and their parents, along with whole-genome and whole-exome sequences generated by contest sponsors Life Technologies Corporation and Complete Genomics.

Twenty-three teams went on to submit complete entries, reviewed by an independent panel of judges using predefined criteria. While many entries got high marks, the Brigham and Women's team was judged to have the best combination of cutting-edge bioinformatic analysis, clarity and utility of its clinical reports for the three families, and appropriate identification of the families' likely genetic defects. The two finalist teams were judged unique and outstanding in one or more areas; the Genomatix team was the only group to correctly flag every likely genetic mutation in all three families, while the University of Iowa team took unique approaches to returning unexpected genetic results based on patient preferences and indicating regions of low coverage or low confidence in their reports.

Answers for families

For one of the three families, CLARITY solved a mystery more than a decade old. Sixth-grader Adam Foye had undergone testing for every gene known to explain his type of muscle weakness, a condition called centronuclear myopathy, always with negative findings. He also has hearing impairment.

Eight of the 23 CLARITY contestants identified alterations in a gene called titin as the cause of Adam's muscle weakness, and six teams identified mutations in a gene called GJB2 as the likely cause of his hearing loss. These results were judged to be correct, and three teams made both identifications.

CLARITY co-organizer Alan Beggs, Ph.D., director of the Manton Center for Orphan Disease Research at Boston Children's, had independently identified titin mutations in four other patients with centronuclear myopathy by using whole-exome sequencing. "Even if we had suspected titin mutations in Adam, it's an enormous gene, and to sequence it individually, by hand, would have taken nine months in the lab, at a prohibitive cost," Beggs says. "That's why genomic sequencing is such a revolutionary technology."

Titin's involvement makes biological sense, Beggs adds, since its protein makes up part of the contractile structure in muscles. Beggs now plans to model the titin defect in zebrafish, allowing his team to do large-scale testing of potential drugs that might correct it.

"We've been celebrating, we've been waiting for an answer for 11 years," says Sarah Foye, Adam's mother. "It doesn't mean we know the treatment now, but it's pointing us in the right direction and we can cross other possibilities off the list."

The contest also identified a probable cause for heart rhythm disturbances in the second family, whose son Liam Burns died 12 days after birth: mutation of a gene called TRPM4, cited by seven teams as likely to be causative. In addition to rhythm disturbances, Liam and several other family members had structural heart defects that remain unexplained by CLARITY; Boston Children's researchers at The Manton Center are investigating whether the TRPM4 alterations are involved.

The genetic cause of the third child's disorder, another muscle-weakening disease known as nemaline myopathy, remains unclear. In all, seven genetic variants were cited by two or more contestants; four were judged worthy of further investigation, including variants of two genes never before associated with nemaline myopathy. The Manton Center at Boston Children's plans to explore these genes further to see if the variants are causative.

Guidance for best practices

There was considerable variability among the contestants' techniques and findings, to be described in the forthcoming paper. However, the teams that were finalists had methods and results that were sound and substantially similar, says Margulies.

"When these best practices are disseminated, skilled practitioners around the world will be able to benchmark themselves against them," he says. "Through CLARITY, we've learned that the best teams in the world, when given raw sequence data, agree fairly closely on results, the meaning of the results and how to deliver them. The best teams were able to elucidate a precise cause for previously unexplained genetic disorders."

"The contestants have demonstrated that genomics, bioinformatics and biotechnology can now have routine relevance in clinical care," says Isaac Kohane, MD, Ph.D., chair of the Children's Hospital Informatics Program and CLARITY's third co-organizer. "They also demonstrate the range of disciplines required to safely and rapidly interpret the millions of variants that are present in all of our genomes."

The CLARITY team plans a second challenge around interpretation of cancer genomes, and will lead a Clinical Bioinformatics Summit in Boston next spring to hammer out the details.

"It is essential that families are cared for by practitioners who are trained in the use of genomic analysis," notes Margulies. "Training of care providers will be the next challenge."

For further background, visit www.childrenshospital.org/CLARITY, and see:

Boston Children's Hospital is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 1,100 scientists, including nine members of the National Academy of Sciences, 11 members of the Institute of Medicine and nine members of the Howard Hughes Medical Institute comprise Boston Children's research community. Founded as a 20-bed hospital for children, Boston Children's today is a 395-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Boston Children's also is a teaching affiliate of Harvard Medical School. For more information about research and clinical innovation at Boston Children's, visit: http://vectorblog.org/.

CONTACT:
Keri Stedman
Boston Children's Hospital
617-919-3110 
(cell 774-244-6490 at ASHG meeting) 
keri.stedman@childrens.harvard.edu

Cathy Yarbrough  
ASHG
858-243-1814
press@ashg.org

SOURCE Boston Children's Hospital

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that Synametrics Technologies will exhibit at SYS-CON's 22nd International Cloud Expo®, which will take place on June 5-7, 2018, at the Javits Center in New York, NY. Synametrics Technologies is a privately held company based in Plainsboro, New Jersey that has been providing solutions for the developer community since 1997. Based on the success of its initial product offerings such as WinSQL, Xeams, SynaMan and Syncrify, Synametrics continues to create and hone inn...
Cloud Expo | DXWorld Expo have announced the conference tracks for Cloud Expo 2018. Cloud Expo will be held June 5-7, 2018, at the Javits Center in New York City, and November 6-8, 2018, at the Santa Clara Convention Center, Santa Clara, CA. Digital Transformation (DX) is a major focus with the introduction of DX Expo within the program. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive ov...
A strange thing is happening along the way to the Internet of Things, namely far too many devices to work with and manage. It has become clear that we'll need much higher efficiency user experiences that can allow us to more easily and scalably work with the thousands of devices that will soon be in each of our lives. Enter the conversational interface revolution, combining bots we can literally talk with, gesture to, and even direct with our thoughts, with embedded artificial intelligence, whic...
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. In his session at @BigDataExpo, Jack Norris, Senior Vice President, Data and Applications at MapR Technologies, reviewed best practices to ...
Continuous Delivery makes it possible to exploit findings of cognitive psychology and neuroscience to increase the productivity and happiness of our teams. In his session at 22nd Cloud Expo | DXWorld Expo, Daniel Jones, CTO of EngineerBetter, will answer: How can we improve willpower and decrease technical debt? Is the present bias real? How can we turn it to our advantage? Can you increase a team’s effective IQ? How do DevOps & Product Teams increase empathy, and what impact does empath...
DevOps promotes continuous improvement through a culture of collaboration. But in real terms, how do you: Integrate activities across diverse teams and services? Make objective decisions with system-wide visibility? Use feedback loops to enable learning and improvement? With technology insights and real-world examples, in his general session at @DevOpsSummit, at 21st Cloud Expo, Andi Mann, Chief Technology Advocate at Splunk, explored how leading organizations use data-driven DevOps to close th...
As many know, the first generation of Cloud Management Platform (CMP) solutions were designed for managing virtual infrastructure (IaaS) and traditional applications. But that's no longer enough to satisfy evolving and complex business requirements. In his session at 21st Cloud Expo, Scott Davis, Embotics CTO, explored how next-generation CMPs ensure organizations can manage cloud-native and microservice-based application architectures, while also facilitating agile DevOps methodology. He expla...
Smart cities have the potential to change our lives at so many levels for citizens: less pollution, reduced parking obstacles, better health, education and more energy savings. Real-time data streaming and the Internet of Things (IoT) possess the power to turn this vision into a reality. However, most organizations today are building their data infrastructure to focus solely on addressing immediate business needs vs. a platform capable of quickly adapting emerging technologies to address future ...
Most technology leaders, contemporary and from the hardware era, are reshaping their businesses to do software. They hope to capture value from emerging technologies such as IoT, SDN, and AI. Ultimately, irrespective of the vertical, it is about deriving value from independent software applications participating in an ecosystem as one comprehensive solution. In his session at @ThingsExpo, Kausik Sridhar, founder and CTO of Pulzze Systems, discussed how given the magnitude of today's application ...
With tough new regulations coming to Europe on data privacy in May 2018, Calligo will explain why in reality the effect is global and transforms how you consider critical data. EU GDPR fundamentally rewrites the rules for cloud, Big Data and IoT. In his session at 21st Cloud Expo, Adam Ryan, Vice President and General Manager EMEA at Calligo, examined the regulations and provided insight on how it affects technology, challenges the established rules and will usher in new levels of diligence arou...
There is a huge demand for responsive, real-time mobile and web experiences, but current architectural patterns do not easily accommodate applications that respond to events in real time. Common solutions using message queues or HTTP long-polling quickly lead to resiliency, scalability and development velocity challenges. In his session at 21st Cloud Expo, Ryland Degnan, a Senior Software Engineer on the Netflix Edge Platform team, will discuss how by leveraging a reactive stream-based protocol,...
Mobile device usage has increased exponentially during the past several years, as consumers rely on handhelds for everything from news and weather to banking and purchases. What can we expect in the next few years? The way in which we interact with our devices will fundamentally change, as businesses leverage Artificial Intelligence. We already see this taking shape as businesses leverage AI for cost savings and customer responsiveness. This trend will continue, as AI is used for more sophistica...
In his session at 21st Cloud Expo, Raju Shreewastava, founder of Big Data Trunk, provided a fun and simple way to introduce Machine Leaning to anyone and everyone. He solved a machine learning problem and demonstrated an easy way to be able to do machine learning without even coding. Raju Shreewastava is the founder of Big Data Trunk (www.BigDataTrunk.com), a Big Data Training and consulting firm with offices in the United States. He previously led the data warehouse/business intelligence and B...
In his general session at 21st Cloud Expo, Greg Dumas, Calligo’s Vice President and G.M. of US operations, discussed the new Global Data Protection Regulation and how Calligo can help business stay compliant in digitally globalized world. Greg Dumas is Calligo's Vice President and G.M. of US operations. Calligo is an established service provider that provides an innovative platform for trusted cloud solutions. Calligo’s customers are typically most concerned about GDPR compliance, application p...
Digital transformation is about embracing digital technologies into a company's culture to better connect with its customers, automate processes, create better tools, enter new markets, etc. Such a transformation requires continuous orchestration across teams and an environment based on open collaboration and daily experiments. In his session at 21st Cloud Expo, Alex Casalboni, Technical (Cloud) Evangelist at Cloud Academy, explored and discussed the most urgent unsolved challenges to achieve f...